Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Owlet (OWLT) Non-cash Items (2020 - 2021)

Owlet (OWLT) reported Non-cash Items of $41.3 million for Q3 2021, down 58.46% on a QoQ basis from $99.3 million in Q4 2020.

Owlet (OWLT) has 2 years of Non-cash Items data on file, last reported at $41.3 million in Q3 2021.

  • Quarterly Non-cash Items changed N/A year-over-year to $41.3 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $41.3 million (changed N/A YoY) and the FY2020 annual result came in at $99.3 million, changed N/A from the prior year.
  • Non-cash Items slipped to $41.3 million in Q3 2021 per OWLT's latest filing, from $99.3 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $99.3 million in Q4 2020 and bottomed at $41.3 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Owlet 150.10 Mn 109.09 Mn 12.24 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 41.25 Mn
Sep 30, 2021 41.25 Mn
Dec 31, 2020 99.30 Mn
Dec 31, 2020 99.30 Mn